|
Market Closed -
Hong Kong S.E.
06:08:32 18/09/26 pm AEST
|
5-day change | 1st Jan Change | ||
| 1.200 HKD | -11.76% |
|
-25.00% | -73.57% |
| 03/09 | Cutia Therapeutics' Marketing Application for Botox Product Accepted in China | MT |
| 03/09 | Cutia Therapeutics Announces Biologics License Application for Cu-20101 Accepted by Nmpa | CI |
| Market Cap | 422M 494M 62.99M 54.86M 51.92M 47.17M 88.13M 6.03B 88.56M 618M 239M 3.07B 237M 231M 9.81B | P/E 2026 * |
38.8x | P/E 2027 * | 8.3x |
|---|---|---|---|---|---|
| Enterprise Value | 491M 575M 73.23M 63.78M 60.37M 54.85M 102M 7.01B 103M 719M 278M 3.56B 275M 269M 11.41B | EV / Sales 2026 * |
0.84x | EV / Sales 2027 * | 0.44x |
| Free-Float |
32.66% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | -11.76% | ||
| 1 week | -25.00% | ||
| Current month | -37.17% | ||
| 1 month | -45.21% | ||
| 3 months | -62.50% | ||
| 6 months | -76.19% | ||
| Current year | -73.57% |
| 1 week | 1.15 |  | 1.54 |
| 1 month | 1.15 | | 2.21 |
| Current year | 1.15 | | 5.51 |
| 1 year | 1.15 | | 9.9 |
| 3 years | 1.15 | | 25 |
| 5 years | 1.15 | | 32.6 |
| 10 years | 1.15 | | 32.6 |
| Manager | Title | Age | Since |
|---|---|---|---|
Le Le Zhang
CEO | Chief Executive Officer | 48 | 01/09/2019 |
Yu Qing Huang
DFI | Director of Finance/CFO | 36 | 10/05/2021 |
Lei Lei
CTO | Chief Tech/Sci/R&D Officer | 42 | 10/01/2020 |
| Director | Title | Age | Since |
|---|---|---|---|
Le Le Zhang
BRD | Director/Board Member | 48 | 12/05/2020 |
Lian Yong Chen
CHM | Chairman | 63 | 23/08/2019 |
Yu Qing Huang
BRD | Director/Board Member | 36 | 15/11/2022 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 15/10/24 | Other | Founder | 15,000 | 0.0049% | ||
| 3/10/24 | Other | Chief Financial Officer | 20,000 | 0.0066% | ||
| 2/10/24 | Other | Chief Financial Officer | 30,000 | 0.0098% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -11.76% | -25.00% | -87.63% | -94.73% | 62.99M | |
| +1.28% | +2.62% | +51.61% | +100.19% | 1,027B | |
| +1.10% | +1.45% | +52.49% | +67.37% | 651B | |
| +0.58% | +3.54% | +19.57% | +73.56% | 467B | |
| +0.37% | +5.72% | +39.16% | +41.07% | 350B | |
| +0.22% | +3.87% | +20.35% | +26.47% | 268B | |
| +0.58% | +6.92% | +11.29% | +16.69% | 257B | |
| +0.91% | -0.70% | +38.25% | +45.67% | 205B | |
| +1.29% | +2.59% | -27.75% | -56.40% | 190B | |
| +2.17% | +4.20% | +34.41% | +99.41% | 187B | |
| Average | -1.10% | +0.74% | +15.18% | +31.93% | 360.22B | |
| Weighted average by Cap. | -0.19% | +2.62% | +35.37% | +62.22% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 588M 688M 87.67M 76.36M 72.27M 65.67M 123M 8.4B 123M 861M 333M 4.27B 329M 322M 13.66B | 961M 1.12B 143M 125M 118M 107M 200M 13.72B 201M 1.41B 544M 6.97B 538M 526M 22.33B |
| Net income | 10M 11.7M 1.49M 1.3M 1.23M 1.12M 2.09M 143M 2.1M 14.64M 5.66M 72.57M 5.6M 5.48M 232M | 50M 58.49M 7.46M 6.49M 6.15M 5.58M 10.43M 714M 10.48M 73.2M 28.3M 363M 28.01M 27.38M 1.16B |
| Net Debt | 68.7M 80.37M 10.24M 8.92M 8.44M 7.67M 14.33M 981M 14.4M 101M 38.89M 499M 38.48M 37.62M 1.6B | 136K 159K 20.29K 17.67K 16.72K 15.19K 28.38K 1.94M 28.52K 199K 77.02K 987K 76.21K 74.51K 3.16M |
| Date | Price | Change | Volume |
|---|---|---|---|
| 18/09/26 | HKD 1.200 | -11.76% | 758,800 |
| 17/09/26 | HKD 1.360 | -2.86% | 42,000 |
| 16/09/26 | HKD 1.400 | +2.56% | 30,600 |
| 15/09/26 | HKD 1.365 | -2.50% | 70,600 |
| 14/09/26 | HKD 1.400 | -12.50% | 64,200 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 2487 Stock
Select your edition
All financial news and data tailored to specific country editions
